Anavex Life Sciences Corp. (AVXL)

1.19 -0.11 (-8.46%) USD  |  NASDAQ  |  Oct 30, 16:00
1.19 0.00 (0.00%) Pre-Market: 20:00
More

Anavex Life Sciences Revenue Estimates for Current Quarter

Revenue Estimates for Current Quarter Chart

View Revenue Estimates for Current Quarter for AVXL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Revenue Estimates for Current Quarter Data

View and export this data back to 2024. Start Trial.
Date Value
May 27, 2026 --
April 02, 2026 --
March 31, 2026 --
March 26, 2026 --
March 23, 2026 --
March 19, 2026 --
February 10, 2026 --
February 09, 2026 --
January 20, 2026 --
January 06, 2026 --
December 31, 2025 --
December 19, 2025 --
December 17, 2025 --
December 15, 2025 --
November 28, 2025 --
November 26, 2025 --
November 19, 2025 --
November 14, 2025 --
October 29, 2025 --
Date Value
October 07, 2025 --
September 30, 2025 --
September 10, 2025 --
August 27, 2025 --
August 22, 2025 --
August 13, 2025 --
August 04, 2025 --
June 30, 2025 --
May 16, 2025 --
May 14, 2025 --
May 02, 2025 --
April 07, 2025 --
March 31, 2025 --
February 27, 2025 --
February 18, 2025 --
September 30, 2024 --
August 06, 2024 --
July 29, 2024 --
July 22, 2024 --

Revenue Estimates for Current Quarter Range, Past 5 Years

View Revenue Estimates for Current Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Quarter Benchmarks

View Revenue Estimates for Current Quarter Benchmarks
Start Trial
Vaxcyte, Inc. Upgrade
Foghorn Therapeutics, Inc. Upgrade
Connect Biopharma Holdings Ltd. Upgrade
Caribou Biosciences, Inc. Upgrade
Arrowhead Pharmaceuticals, Inc. Upgrade

Revenue Estimates for Current Quarter Related Metrics

EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade